AUTHOR

Seth Hancock

Seth Hancock is a freelance reporter for The Defender. He has worked in journalism professionally for over 15 years, primarily in local news for a community newspaper, Examiner Publications, in Bartlett, IL. He is also a contributor for The Liberty Loft. Seth has a B.A. in journalism from Western Illinois University.

Seth Hancock's Posts:

At least 25 federal agencies are setting up databases to track federal employees who seek religious exemptions from COVID vaccine mandates.

The Defender

25 Federal Agencies Set Up ‘Orwellian Databases’ to Track Religious Exemption Requests by Federal Employees

Excess deaths are defined as the difference between the observed number of deaths during a specific time frame and the expected number of deaths during that same period.

The Defender

40% Rise Nationwide in Excess Deaths Among 18- to 49-Year-Olds, CDC Data Show

Two media outlets last week requested, but failed to obtain, clarity from Pfizer on whether its fully licensed Comirnaty COVID vaccine is available in the U.S.

The Defender

Pfizer, FDA Dodge Media Questions About Pfizer Comirnaty Vaccine

Days prior to today’s scheduled release of a tranche of documents related to the Pfizer COVID vaccine, the pharmaceutical company asked a federal court to let it intervene before any information is released.

The Defender

FDA Should Need Only ‘12 Weeks’ to Release Pfizer Data, Not 75 Years, Plaintiff Calculates

Three studies released within days of each other show the Pfizer-BioNTech COVID vaccine is less effective against the Omicron variant.

The Defender

Studies Find Pfizer Vaccine Less Effective Against Omicron

The U.S. Senate on Wednesday voted 52 - 48 to overturn President Joe Biden’s COVID vaccine mandate for private businesses with more than 100 employees.

The Defender

Senate Votes to Repeal Biden Vaccine Mandates for Employers

U.S. Rep. Ralph Norman introduced legislation that would require the FDA to release, within 100 days, all records of information submitted to the agency regarding the EUA of, or licensing of, all Pfizer COVID-19 vaccines.

The Defender

Congressman Introduces Bill to Force FDA to Release Pfizer Documents Within 100 Days, Instead of 55 Years

Shares of Moderna jumped 13.61% — $273.39 to $310.61 — between Nov. 24 and Dec. 1, while Pfizer shares increased 7.41% — $50.91 to $54.68, Common Dreams reported.

The Defender

8 Top Pfizer, Moderna Shareholders $10 Billion Richer After Media Hypes Omicron Fears

The FDA Antimicrobial Drugs Advisory Committee voted to recommend EUA of Merck’s five-day pill to treat COVID.

The Defender

FDA Panel Recommends Merck COVID Pill, Despite ‘More Questions Than Answers’